QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=5AD4C6133ACA818024C50947731D98BB;jsessionid=10FFC983A15314F120B78CAEE68677D1;jsessionid=F716B8971AEFA5AC4CC4BE33C1CD9688;jsessionid=EADCAEAE01E82E29B37C33C25F2BC760;jsessionid=C21B77AB91B8334A2B385A14DC1FBDF2 (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=5AD4C6133ACA818024C50947731D98BB;jsessionid=10FFC983A15314F120B78CAEE68677D1;jsessionid=F716B8971AEFA5AC4CC4BE33C1CD9688;jsessionid=EADCAEAE01E82E29B37C33C25F2BC760;jsessionid=C21B77AB91B8334A2B385A14DC1FBDF2